FDSB vs GILD · P/E 18, rev $605.0K vs P/E 18, rev $7.80B
Fifth District Bancorp, Inc. Common Stock (FDSB) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Fifth District Bancorp, Inc. Common Stock (FDSB) is a banks - regional company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported FDSB revenue for 2025-12-31 was $605.0K. Net income was $4.1M. Revenue was down 2.3% from 2024-12-31 to 2025-12-31. FDSB currently screens at market cap $79.3M and trailing P/E 17.5.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
FDSB currently screens at market cap $79.3M and trailing P/E 17.5. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the FDSB and GILD stock pages for the full models.
Not investment advice.